Display options
Cite
Lobo S. Is there enough focus on lipophilicity in drug discovery?. Expert Opin Drug Discov. 2019;15(3):261-263doi: 10.1080/17460441.2020.1691995.
Lobo, S. (2020). Is there enough focus on lipophilicity in drug discovery?. Expert opinion on drug discovery, 15(3), 261-263. https://doi.org/10.1080/17460441.2020.1691995
Lobo, Sonia. "Is there enough focus on lipophilicity in drug discovery?." Expert opinion on drug discovery vol. 15,3 (2020): 261-263. doi: https://doi.org/10.1080/17460441.2020.1691995
Lobo S. Is there enough focus on lipophilicity in drug discovery?. Expert Opin Drug Discov. 2020 Mar;15(3):261-263. doi: 10.1080/17460441.2020.1691995. Epub 2019 Nov 17. PMID: 31736369.
Copy Download .nbib Format: NLM
Share it on

Expert Opin Drug Discov. 2020 Mar;15(3):261-263. doi: 10.1080/17460441.2020.1691995. Epub 2019 Nov 17.

Is there enough focus on lipophilicity in drug discovery?.

Expert opinion on drug discovery

Sonia Lobo

Affiliations

  1. Department of Medical Education, Geisinger Commonwealth School of Medicine, Scranton, PA, USA.

PMID: 31736369 DOI: 10.1080/17460441.2020.1691995

[No abstract available.]

Keywords: ADMET; Lipophilicity; drug development; physiochemical properties

Substances

MeSH terms

Publication Types